A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation
Condition: Recurrent Hepatocellular Carcinoma Intervention: Biological: LioCyx Sponsors: Lion TCR Pte. Ltd.; Agency for Science, Technology and Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Science | Study | Transplants | Urology & Nephrology